The Clinical Relevance of Disturbances of Uterine Vascular Growth, Remodeling, and Repair

In: Vascular Morphogenesis in the Female Reproductive System · 2001 · pp. 223–244 · doi:10.1007/978-1-4612-0213-4_12 · W1629103966
book-chapter OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-09

Endometrial blood vessels cyclically grow, remodel, and repair, with disruptions causing controlled menstruation, all regulated by complex cellular and molecular processes that can be disturbed.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometrial blood vessels are unique in the manner in which they undergo monthly cycles of dramatic growth, disruption, remodeling, and repair, rivaled only by the remarkable vascular growth and regression occurring during formation and subsequent demise of the ovarian corpus luteum. In the normal menstrual cycle the regular endometrial vascular and tissue disruption and remodeling is associated with frank bleeding known as menstruation. The volume and duration of this bleeding is generally very precisely controlled by a number of fail-safe mechanisms. The overall cyclical changes occurring in endometrium are regulated by a complex sequence of interacting cellular and molecular processes. Any of these processes may be disturbed under certain circumstances.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-13T17:26:54.343160+00:00
License: CC0 · commercial use OK